Get Your Georgia Medical Marijuana Card Online

To obtain your Georgia Medical Cannabis Registry Card, you must first complete a 10-to-15 minute telehealth evaluation with a state-licensed physician. If approved, the doctor will immediately upload your certification and a signed state waiver form directly into the Georgia Department of Public Health (DPH) secure portal.

Once your $30 state fee is processed, the state prints your physical ID card and ships it securely via UPS (requiring an adult signature), or coordinates a pickup at a designated county health department. Under SB 220 (effective July 1, 2026), patients can also elect a digital electronic registry card that is delivered immediately upon DPH approval and authorizes dispensary pickup as soon as it is received.

Patient requirements per Georgia Code Title 31 Chapter 2A and Georgia DPH Medical Cannabis Registry.

SB 220 (the Putting Georgia's Patients First Act) was signed into law by Governor Brian Kemp on May 13, 2026 and takes effect on **July 1, 2026**. It is the largest expansion of Georgia's medical cannabis program since the original 2015 Haleigh's Hope Act.

SB 220 eliminates the legacy 5% THC potency cap and CBD-balance rule (replacing them with a 1,200 mg per-package THC ceiling and a 12,000 mg cumulative possession limit), authorizes vaporization for patients 21 and older (vape cartridges, concentrates, and vaporized flower) that phases in as the state issues ingestion rules due January 1, 2027, expands the caregiver definition to three statutory categories, opens a 45-day out-of-state reciprocity window for visiting patients, introduces digital electronic registry cards, adds Lupus as a new qualifying condition, expands cancer eligibility to any cancer except non-metastatic skin cancer, renames Crohn's Disease to Inflammatory Bowel Disease, and renames AIDS to HIV Stage III. Smoking or combusting cannabis and edible food products (gummies, cookies, candies) remain prohibited under Georgia law even after SB 220.

SB 220 (the Putting Georgia's Patients First Act), signed May 13, 2026, effective July 1, 2026.

Yes. Your existing 5-year Georgia Patient Registry ID remains valid through its original expiration date after SB 220 takes effect on July 1, 2026. You do not need to reapply, pay a new state fee, or visit a physician earlier than your normal renewal cycle.

Starting July 1, 2026, the legacy 5% THC cap is gone, so the oils, tinctures, capsules, patches, and lotions already on shelves can be sold at full potency at the same dispensaries and pharmacies where you currently shop. SB 220 also authorizes vaporization for patients 21 and older (vape cartridges, concentrates, and vaporized flower), which phases in as the state issues ingestion rules due January 1, 2027. If your qualifying condition was renamed under SB 220 (Crohn's Disease to Inflammatory Bowel Disease, or AIDS to HIV Stage III), the rename is automatic on the state registry and does not require any action from you. The only change you may need to plan for is the new annual physician recertification requirement, which applies to patients with potentially-resolving conditions; patients with incurable or irreversible conditions are exempt.

Card continuity and product-catalog expansion per SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

Eventually yes, but not necessarily on July 1, 2026. SB 220 authorizes vaporization for registered patients aged 21 and older (vape cartridges, concentrates, and vaporized flower), but this route phases in as the Georgia Access to Medical Cannabis Commission and Department of Public Health issue ingestion rules, which are due by January 1, 2027. The change patients see first on July 1, 2026 is the removal of the 5% THC cap on the existing oils, tinctures, capsules, transdermal patches, and lotions. Patients under 21 remain limited to those non-vaporized formats.

Each individual product package is capped at 1,200 mg of THC, and your cumulative possession limit across all products is 12,000 mg of THC. Smoking or combusting cannabis and edible food products (gummies, cookies, candies, chocolates, baked goods) remain prohibited under Georgia law even after SB 220. The 21-and-older age limit on vaporization formats is a statutory rule under SB 220, not a dispensary policy; pharmacists and dispensary staff verify age against your government-issued photo ID at pickup.

Vape cartridges and concentrates for patients 21 and older authorized by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026; 1,200 mg per-package THC ceiling per O.C.G.A. §16-12-200 et seq.

Yes. The Georgia Composite Medical Board officially voted to mirror federal guidelines, extending all parallel telemedicine flexibilities through **December 31, 2026**.

Georgia residents can comforably establish a bona fide doctor-patient relationship and complete their entire medical evaluation from home via secure video or phone consultation.

Telehealth extended per Georgia Composite Medical Board ruling.

Under OCGA §31-2A-18(a)(3), as amended by SB 220 (effective July 1, 2026), Georgia recognizes 17 lettered qualifying conditions plus a separate eligibility pathway for hospice patients under §31-2A-18(d). SB 220 surgically updated the list: cancer eligibility was expanded to any cancer except non-metastatic skin cancer, Crohn's Disease was renamed to Inflammatory Bowel Disease, AIDS was renamed to HIV Stage III, Intractable Pain was given a strict 6-month statutory definition, and Lupus was newly added.

The full 17 conditions are: Cancer (any cancer except non-metastatic skin cancer), ALS (severe or end stage), Seizure Disorders (epilepsy or trauma-related head injuries), MS (severe or end stage), Inflammatory Bowel Disease, Mitochondrial Disease, Parkinson's Disease (severe or end stage), Sickle Cell Disease (severe or end stage), Tourette's Syndrome (severe), Autism Spectrum Disorder (adults 18+, or minors with severe autism), Epidermolysis Bullosa, Alzheimer's Disease (severe or end stage), HIV Stage III, Peripheral Neuropathy (severe or end stage), PTSD (patients 18+), Intractable Pain (cause cannot be removed; full range of pain management used 6+ months without adequate results or with intolerable side effects), and Lupus. Hospice patients (inpatient or outpatient) qualify separately under §31-2A-18(d) without a qualifying-condition diagnosis.

Qualifying conditions per OCGA §31-2A-18(a)(3) and SB 220 (the Putting Georgia's Patients First Act, effective July 1, 2026).

Georgia patients can buy approved cannabis formulations from standard medical dispensaries (operated by licensed entities like Trulieve Georgia and Botanical Sciences) as well as **over 56 licensed independent pharmacies** across the state.

The Georgia Access to Medical Cannabis Commission (GMCC) manages and maps all active dispensing licenses at gmcc.ga.gov.

Dispensary and pharmacy sales per Georgia Access to Medical Cannabis Commission (GMCC).

No. Home cultivation of cannabis remains a severe felony offense in Georgia for all residents, regardless of medical registry status.

There are no patient or caregiver cultivation allowances under state law. All medical cannabis products must be purchased exclusively from state-licensed dispensaries or authorized pharmacies.

Home cultivation strictly prohibited under Georgia Code Title 31 Chapter 2A.

Yes, for 45 days. Under SB 220 (effective July 1, 2026), Georgia honors a valid, unexpired medical cannabis card from any U.S. state for 45 days from the visiting patient's first in-state purchase at a Georgia dispensing pharmacy.

Visiting patients must present a matching government-issued photo ID alongside their home-state card. They are bound by the same 12,000 mg cumulative THC possession cap and 1,200 mg per-package ceiling as Georgia residents. Anyone planning to remain in Georgia beyond 45 days must enroll directly in the Georgia Medical Cannabis Registry through the Georgia Department of Public Health.

45-day non-resident recognition established by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

It depends on the license type. Under O.C.G.A. §3-3-21(a)(1), as enacted by SB 220 effective July 1, 2026, Commission-issued dispensing licenses cannot be located in any precinct where the retail sale of distilled spirits is prohibited. State Board of Pharmacy licenses are expressly exempt from the restriction, so SBP-licensed independent pharmacies may continue to dispense medical cannabis in dry counties and dry precincts where standalone Commission-licensed dispensaries cannot operate.

Georgia operates a dual-track dispensing-license framework under O.C.G.A. §16-12-206, with the Georgia Access to Medical Cannabis Commission (GMCC) and the State Board of Pharmacy (SBP) both authorized to issue dispensing licenses. For patients living in dry-county Georgia, the local SBP-licensed pharmacy is often the only in-county legal pickup point for medical cannabis.

Dry-county dispensing-location rule and pharmacy exemption per O.C.G.A. §3-3-21(a)(1) as enacted by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

Yes. Under O.C.G.A. §16-12-230(b), as enacted by SB 220 effective July 1, 2026, pharmacists filling a medical cannabis dispense must first query the Georgia Prescription Drug Monitoring Program (PDMP), the same statewide controlled-substances database that already governs opioid and benzodiazepine dispensing in the state.

The PDMP check happens on the pharmacist's side at pickup, so patients do not need to do anything extra. The provision aligns medical cannabis with how other scheduled medications are handled in Georgia pharmacy practice and provides a patient-safety check against duplicative prescribing across providers.

Pharmacist PDMP check requirement per O.C.G.A. §16-12-230(b) as enacted by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

SB 220 (effective July 1, 2026) expanded the eligible-caregiver definition from one category to three: (A) the patient's parent, guardian, or legal custodian (legacy, retained); (B) any adult the patient designates to assist with purchasing, possessing, or administering medical cannabis (NEW, unlocks adult-child caregivers, spouses, partners, friends, neighbors, and household helpers); and (C) the health care institution where the patient is receiving care (NEW, includes hospitals, hospices, nursing homes, assisted-living facilities, and residential care facilities).

Individual caregivers under (A) and (B) must be 21 years of age or older, must be Georgia residents, and must pass a state criminal background check with fingerprinting (10-year lookback, felony drug and violent-crime disqualifiers). Caregiver registry cards cost $30 plus a $3.75 processing fee, are valid 5 years, and may be issued in physical, electronic, or both formats under SB 220. Health care institutions under category (C) follow a separate institutional designation pathway through the Georgia Department of Public Health.

Caregiver-definition expansion per O.C.G.A. §31-2A-2(2) as amended by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

It depends on your qualifying condition. SB 220 retained the 5-year card framework but layered on an annual physician recertification requirement for the patient's underlying certification, UNLESS your qualifying condition is incurable or irreversible. Most of Georgia's qualifying conditions fall within the exemption (ALS, MS, Parkinson's, Alzheimer's, Sickle Cell, Lupus, Mitochondrial Disease, Epidermolysis Bullosa, Autism Spectrum Disorder, HIV Stage III, Inflammatory Bowel Disease, and Intractable Pain by its statutory definition).

Patients with potentially-resolving conditions (treatable cancers, trauma-related seizure disorders, treatable PTSD, treatable peripheral neuropathy) should expect a $149.99 annual physician recertification visit during the 5-year card period. The registry card itself remains valid 5 years from issuance regardless of which group you fall into. MMJ.com supports both first-time evaluations and annual recertification visits via telehealth.

Annual physician recertification with incurable-or-irreversible exemption per SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

Not for authorized persons. SB 220 (effective July 1, 2026) amended Georgia's Controlled Substances Act so the statutory definitions of "marijuana" and Schedule I now expressly exclude medical cannabis and medical cannabis products when held by an authorized person: a registered patient, registered caregiver, licensed Commission or State Board of Pharmacy licensee, or pharmacist dispensing under O.C.G.A. §16-12-230.

Pre-SB 220, possession of medical cannabis was technically possession of a Schedule I controlled substance with an affirmative defense available to cardholders. Post-SB 220, possession by an authorized person is expressly NOT a Schedule I controlled substance under Georgia law. The carve-out applies at the definitional level rather than as an affirmative defense, which simplifies law-enforcement interactions for cardholders presenting a valid registry card. Federal law (the Controlled Substances Act of 1970) still classifies marijuana as Schedule I; the SB 220 exclusion applies only to Georgia state law.

Schedule I and marijuana-definition carve-out per O.C.G.A. §§16-13-21 and 16-13-25 as amended by SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.

No. SB 220 (effective July 1, 2026) prohibits public use of medical cannabis, including vaporization. Use must occur in a private residence, in a private vehicle that is not in use on a public roadway, or, for institutionally-cared-for patients, within the licensed health care facility.

Vaporization in parks, on sidewalks, in restaurants, in retail premises, in workplaces open to the public, and on public transit is prohibited regardless of patient or caregiver status. Combustion (smoking) of cannabis plant material remains prohibited entirely under any setting. Vaporization is permitted only for patients 21 and older and only in non-public settings.

Public-use prohibition per SB 220 (the Putting Georgia's Patients First Act), effective July 1, 2026.